Yaghoubifard S - Search Results

1

From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?

Hashemi-Meshkini A, Varmaghani M, Yousefi M, Yaghoubifard S, Zekri HS, Nikfar S, Kebriaeezadeh A. Hashemi-Meshkini A, et al. Among authors: yaghoubifard s. J Res Pharm Pract. 2014 Jul;3(3):88-93. doi: 10.4103/2279-042X.141101. J Res Pharm Pract. 2014. PMID: 25328898 Free PMC article.

2

Developing a conceptual framework and a tool for measuring access to, and use of, medicines at household level (HH-ATM tool).

Yaghoubifard S, Rashidian A, Kebriaeezadeh A, Majdzadeh R, Hosseini SA, Akbari Sari A, Salamzadeh J. Yaghoubifard S, et al. Public Health. 2015 May;129(5):444-52. doi: 10.1016/j.puhe.2015.01.026. Epub 2015 Mar 11. Public Health. 2015. PMID: 25769347

3

Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis.

Varmaghani M, Meshkini AH, Farzadfar F, Yousefi M, Yaghoubifard S, Varahrami V, Darzi ER, Anabi M, Kebriaeezadeh A, Zekri HS. Varmaghani M, et al. Among authors: yaghoubifard s. J Res Pharm Pract. 2015 Apr-Jun;4(2):51-6. doi: 10.4103/2279-042X.155750. J Res Pharm Pract. 2015. PMID: 25984541 Free PMC article.

4

Developing a patient satisfaction questionnaire for services provided in Iranian community pharmacies.

Yaghoubifard S, Rashidian A, Kebriaeezadeh A, Sheidaei A, Varmaghani M, Hashemi-Meshkini A, Zekri HS. Yaghoubifard S, et al. J Res Pharm Pract. 2016 Apr-Jun;5(2):106-15. doi: 10.4103/2279-042X.179572. J Res Pharm Pract. 2016. PMID: 27162804 Free PMC article.

5

Evaluation of COVID-19 Treatments in Iran in Comparison with Local Therapeutic Recommendations: A Population-Level Study on Utilization and Costs of Prescription Drugs.

Hashemi-Meshkini A, Koochak R, Nikfar S, Rezaei-Darzi E, Yaghoubifard S. Hashemi-Meshkini A, et al. Among authors: yaghoubifard s. J Res Pharm Pract. 2022 Aug 18;11(1):1-7. doi: 10.4103/jrpp.jrpp_6_22. eCollection 2022 Jan-Mar. J Res Pharm Pract. 2022. PMID: 36277970 Free PMC article.

6

Clinical Effectiveness of Erlova in EGFR-Mutated Non-Small Cell Lung Cancer: An Affordable Price with Clinical Benefit.

Seifi S, Salimi B, Esfahani-Monfared Z, Radmanesh R, Yaghoubifard S, Talebianpour S, Khosravi A. Seifi S, et al. Among authors: yaghoubifard s. Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1155-1158. doi: 10.31557/APJCP.2022.23.4.1155. Asian Pac J Cancer Prev. 2022. PMID: 35485670 Free PMC article.

7

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran.

Hashemi-Meshkini A, Tajik A, Ayati N, Nikfar S, Koochak R, Yaghoubifard S, Abbasi A, Varmaghani M. Hashemi-Meshkini A, et al. Among authors: yaghoubifard s. J Tehran Heart Cent. 2023 Apr;18(2):94-101. doi: 10.18502/jthc.v18i2.13318. J Tehran Heart Cent. 2023. PMID: 37637281 Free PMC article.

8

Cost-effectiveness analysis of dialysis and kidney transplant in patients with renal impairment using disability adjusted life years in Iran.

YaghoubiFard S, Goudarzi R, Etminan A, Baneshi M, Barouni M, Jafari Sirizi M. YaghoubiFard S, et al. Med J Islam Repub Iran. 2016 Jun 28;30:390. eCollection 2016. Med J Islam Repub Iran. 2016. PMID: 27493934 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters